NVE Corp will release its financial results for the second quarter of fiscal year 2026 on Wednesday, October 21, 2026. The announcement is scheduled for after the close of the Nasdaq Regular Market.

Conference Call Details

The company will host a quarterly conference call later that day at 4:00 pm Central Time. Investors and interested parties can access the live webcast in listen-only mode via the Investor Events page on the company's website. An archive of the call will also be made available on the site following the event.

For those wishing to participate by phone or request to ask questions, dial-in instructions have been provided. Participants should call 419-945-6082 and enter Meeting PIN: 320 883 894#. Alternatively, questions can be submitted by logging into the designated Google Meet link provided in the company's investor relations materials.

Company Profile

NVE is a leader in the practical commercialization of spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. The company manufactures high-performance spintronic products, including sensors and couplers used for data acquisition and transmission.

Forward-Looking Statements

Statements regarding future plans, events, financial results, or performance are forward-looking statements subject to risks and uncertainties. These include risk factors listed in filings with the SEC, such as the Annual Report on Form 10-K for the fiscal year ended March 31, 2026.

NVE Corporation (NASDAQ: NVEC) reported an 81% revenue increase to $11 million for the quarter ended June 30, 2026, marking the start of FY27. Net income rose 79% to $6.39 million, or $1.32 per diluted share, supported by strong semiconductor market demand and new product sales.

Financial Performance

Total revenue climbed from $6.1 million in the prior-year quarter, driven by an 82% jump in product sales and a 53% rise in contract R&D revenue. Product sales expanded across defense and non-defense lines as well as distributor and direct channels.

Gross margin improved to 81.3% from 80.6% in the prior-year period, aided by higher volumes. Total expenses increased 49%, which was significantly lower than the revenue growth rate. Consequently, expenses as a percentage of revenue fell from 19% to 15%. This operational leverage contributed to a net margin expansion to 58%, up from a lower base implied by the prior year's figures.

What the Numbers Show

The divergence between the 81% revenue growth and the 49% expense growth highlights significant operating leverage. While R&D expenses rose 31% due to staffing and new product development, and SG&A expenses surged 81% primarily due to performance-based compensation, the overall expense ratio contracted sharply. This indicates that top-line volume gains are currently outweighing the cost of scaling sales and development efforts.

Balance Sheet and Cash Flow

Cash plus marketable securities increased by $391,000 to $43.9 million as of June 30, compared to $43.5 million at the end of March 2026. Fixed asset purchases dropped to $57,000 for the quarter from $1.06 million in the same period last year, reflecting the completion of a two-year, multi-million-dollar capacity expansion. Inventories decreased by 6% due to increased product sales.

Interest income declined 10% due to a reduction in the marketable securities portfolio, as proceeds from bond maturities in the prior fiscal year partially funded dividends and fixed asset purchases. Despite this, earnings more than covered the $1 per share quarterly dividend for the second consecutive quarter.

Strategic Updates

Pete Eames succeeds Dan Baker as CEO, effective August following the annual meeting. Baker will remain on the Board as Chairman. The Board also nominated Carolyn Valentine, expanding its size from five to seven directors to strengthen corporate governance.

New product launches include wafer-level chip-scale sensors for implantable medical devices, featuring MRI-safe capabilities stable up to over 9 Tesla. The company is also developing precise sensors for robotics and efficient isolators for power conversion, targeting high-growth markets such as humanoid robotics and AIoT.